Accordingly, overexpression or pharmacological stimulation of TRPV4 with GSK1016790A has been shown to lead to a “normalization” of the vascular endothelium, enhancing the permeability of chemotherapeutic drugs, and basically blocking tumor growth (Adapala et al., 2016). This evidence concerns the gene TRPV4 and neoplasm.